Found 282 matching trials
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia EARLY_PHASE1 The main objective of this study is to observe and evaluate the safety and ...
Show More Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer. PHASE2 This is a single-arm, open-label, prospective clinical study aimed at obser...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies PHASE1 The study is being conducted to evaluate the Safety, Tolerability, Pharmaco...
Show More Location
Multiple Locations
Learn More & Join Trial
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy PHASE2 Head and neck cancer is the malignant tumor with the highest morbidity and ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients PHASE3 This is a multicenter, randomized controlled, phase III clinical trial. The...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma PHASE2 The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Learn More & Join Trial
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma N/A Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer PHASE2 The investigators propose to initiate a study assessing the efficacy and sa...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma PHASE2 This phase II randomized trial compares the efficacy and safety of Toripali...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial
JS001+IMP4297 in Patients With Advanced Cancer PHASE1 This is a Phase I/Ib open-label, multicenter study to evaluate the safety, ...
Show More Location
Multiple Locations
Learn More & Join Trial